Technical Analysis for SNN - Smith & Nephew SNATS, Inc.

Grade Last Price % Change Price Change
grade A 41.81 0.22% 0.09
SNN closed up 0.22 percent on Monday, May 20, 2019, on 64 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical SNN trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Overbought Stochastic Strength 0.22%
Overbought Stochastic Strength -0.81%
Narrow Range Bar Range Contraction -0.81%
NR7 Range Contraction -0.81%
Overbought Stochastic Strength -0.81%
Narrow Range Bar Range Contraction -1.16%
Overbought Stochastic Strength -1.16%
Narrow Range Bar Range Contraction -0.71%

Older signals for SNN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company's Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and orthopaedic trauma fixation products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, such as cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company's Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. The company's principal products include ALLEVYN and DURAFIBER branded wound care products; ACTICOAT branded products for infection management; and negative pressure wound therapy products. Smith & Nephew plc primarily serves medical and surgical service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.
Medicine Medical Specialties Surgery Radio Frequency Healthcare Providers Infection Ancillary Products Orthopedic Surgery Medical Device Minimally Invasive Procedures Implant Deformity Surgical Specialties Burns Minimally Invasive Surgery Sports Medicine Arthroscopy Bone Cement Medicine Products Surgical Devices Wound Wound Care Products
Is SNN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.76
52 Week Low 32.215
Average Volume 500,619
200-Day Moving Average 37.5227
50-Day Moving Average 40.075
20-Day Moving Average 40.8145
10-Day Moving Average 42.043
Average True Range 0.5828
ADX 35.81
+DI 36.3214
-DI 16.4256
Chandelier Exit (Long, 3 ATRs ) 41.0116
Chandelier Exit (Short, 3 ATRs ) 39.4384
Upper Bollinger Band 44.017
Lower Bollinger Band 37.612
Percent B (%b) 0.66
BandWidth 15.692952
MACD Line 0.7407
MACD Signal Line 0.6903
MACD Histogram 0.0504
Fundamentals Value
Market Cap 18.31 Billion
Num Shares 438 Million
EPS 1.96
Price-to-Earnings (P/E) Ratio 21.33
Price-to-Sales 3.57
Price-to-Book 3.97
PEG Ratio 0.00
Dividend 0.62
Dividend Yield 1.48%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.31
Resistance 3 (R3) 42.32 42.17 42.22
Resistance 2 (R2) 42.17 42.04 42.16 42.19
Resistance 1 (R1) 41.99 41.97 41.92 41.98 42.17
Pivot Point 41.84 41.84 41.80 41.83 41.84
Support 1 (S1) 41.66 41.71 41.59 41.65 41.45
Support 2 (S2) 41.51 41.64 41.50 41.43
Support 3 (S3) 41.33 41.51 41.40
Support 4 (S4) 41.32